Clinical trials and equitable care pathways are needed to build on early evidence of benefit Substance use disorders (SUDs) ...

Since 2021, the story of GLP-1s has illustrated that scientific progress is rarely a straight line from hypothesis to patient ...

Researchers at Washington University School of Medicine in St. Louis show in a new study that GLP-1 medications may be ...

Phenomix's MyPhenome test continues to demonstrate predictive accuracy in identifying which patients are most likely to respond to GLP-1 therapies such as semaglutide. Studies presented at Obesity ...

With GLP-1 drugs becoming more accessible and affordable, they could also be within reach for substance use treatment.